Skip to main content
ISOP ACoP 2025 Annual Conference Main banner

Monica Simeoni, PhD (she/her/hers)

Senior Director, Clinical Pharmacology and Quantitative Medicine
GSK, United Kingdom

Monica Simeoni is a senior director, MIDD lead, in the Clinical Pharmacology and Quantitative Medicine department at GSK which she joined in 2006. She is the Model-Based-Meta-Analysis subject matter expert for Respiratory and Immunology therapeutic areas.
After obtaining a Ph.D. in Biomedical Engineering from the Polytechnic of Milan, Italy, she has been an employee of the Department of Computer Science and Systems Engineering, University of Pavia, Italy, assigned to collaborative projects with pharma industry.
She has more than 20 years of experience in the pharmaceutical field. Her therapeutic areas of expertise are immuno-inflammation, neurosciences, oncology and glucose-insulin metabolism. She has experience in non-linear mixed-effect population modelling applied to the pharmacokinetics and pharmacodynamics at clinical and preclinical level, including efficacy and toxicity evaluation and target mediated drug disposition modelling. Further areas of interest are disease progression modeling, joint modelling, estimation methods, covariate analysis, model based meta-analysis.
She is an active memeber of various international scientific organizations:
• She is a member of the Scientific Organizing Committee of the Population Approach Group in Europe (PAGE) conference since 2022.
• She is currently the pharmacometrics (PMx) co-chair in the Stats and Pharmacometrics (SxP) SIG.
o She is member of the MBMA Special Interest sub-Group (subSIG) which she joined in September 2021 and of which she has been the co-chair from August 2022 till April 2024.
o Additionally, she joined the AI/ML subSIG in November 2023.
SxP SIG together with its MBMA and AI/ML subSIGs are sponsored by the American Statistical Association (ASA) and International Society of Pharmacometrics (ISoP).

Disclosure information not submitted.

Presentation(s):